Ki-67 [SP6] Antibody – 153Eu
Isotype: Rabbit IgG
Reactivity: Human*, Mouse*
Background: Ki-67 is a nuclear protein expressed by proliferating cells (cells in G1, S, G2, and mitosis, absent in the G0 resting phase). The Ki-67 protein has a half-life of only 1–1.5 hours. The Ki-67 proliferation index, or fraction of Ki-67-positive tumor cells, is associated with the clinical course of certain cancers, including carcinomas of the prostate, brain and breast and gastroenteropancreatic neuroendocrine tumors. Antisense oligonucleotides and antibodies targeting Ki-67 have been reported to inhibit cell cycle progression.
Validation: Each lot of conjugated antibody is quality control tested by staining tissue following the MIBI Staining Protocol optimized for the applicable tissue format with subsequent MIBIscope analysis of stained tissue microarray using the appropriate positive and negative tissue field of views. These results are pathologist verified.
Recommended Usage: Human and Mouse FFPE: 1:100 dilution.
For optimal results, the antibody should be titrated for each desired application.
MIBI technology: Learn more about MIBI™ Technology, a multiplex IHC technology with unmatched sensitivity and true subcellular resolution.
Li L.T., Jiang G., Chen Q., Zheng J.N. Ki67 is a promising molecular target in the diagnosis of cancer. Mol Med Rep. 2015;11(3):1566-72.
Rahmanzadeh, R., Rai, P., Celli, J.P., Rizvi, I., Baron-Lühr, B., Gerdes, J., Hasan, T. Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer. Cancer Res. 2010; 70(22):9234-42.
* Conjugate tested on human tissue and mouse tissue.